Amphastar Pharmaceuticals Inc (AMPH)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | 2.575 | 1.022 | -1.185 | 8.894 | 0.23 | 9.536 | 12.93 | 12.2 |
Return on Equity (%) | 3.372 | 1.353 | -1.635 | 12.36 | 0.32 | 13.892 | 18.762 | 23.551 |
Return on Invested Capital (%) | 4.923 | 0.589 | -1.061 | -3.285 | 1.89 | 10.793 | 16.513 | 21.26 |
Operating Margin (%) | 6.259 | 1.02 | -3.286 | 18.721 | 1.432 | 19.375 | 23.389 | 30.807 |
Net Profit Margin (%) | 4.128 | 1.877 | -1.947 | 15.182 | 0.401 | 14.189 | 18.314 | 21.345 |
Book Value Per Share | 6.031 | 6.267 | 6.907 | 8.295 | 8.593 | 8.523 | 10.213 | 0.545 |
Earnings Per Share | 0.228 | 0.097 | -0.123 | 1.051 | 0.03 | 1.302 | 1.899 | 2.871 |
Cash Per Share | 1.564 | 1.407 | 1.851 | 1.582 | 1.951 | 2.648 | 3.244 | 3.012 |
Working Capital Per Share | 2.67 | 2.586 | 2.434 | 3.548 | 3.526 | 4.491 | 5.892 | 5.515 |
Operating Profit Per Share | 2.564 | 2.276 | 2.648 | 3.221 | 3.471 | 4.678 | 5.697 | 8.123 |
EBIT Per Share | 0.323 | 0.035 | -0.213 | 1.293 | 0.098 | 1.759 | 2.387 | 3.577 |
EBITDA Per Share | 0.323 | 0.035 | -0.213 | 1.293 | 0.098 | 1.759 | 2.387 | 3.577 |
Free Cash Flow Per Share | 0.379 | 0.521 | 0.527 | 1.554 | 0.289 | 1.385 | 1.874 | 2.874 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 46,25M | 46,62M | 46,63M | 46,58M | 47,5M | 47,72M | 48,11M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 48,11M | 48,27M | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | 24.258 | N/A | N/A | N/A | 32.873 | N/A | N/A |
Net Profit Margin (%) | N/A | 18.591 | N/A | N/A | N/A | 25.127 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 1,75B |
Ratio cours/bénéfice | 12,69 |
Ratio prix/ventes | 2,71 |
Ratio prix/liquidités | 12,1 |
Ratio prix/valeur comptable | 2,73 |
Rendement de dividende | - |
Actions en circulation | 48,08M |
Volume moyen (1 semaine) | 459,29k |
Volume moyen (1 mois) | 630,86k |
Variation sur 52 semaines | -40,91% |
Plus haut sur 52 semaines | 65,9249 |
Plus bas sur 52 semaines | 36,071 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales